To modify provisions relating to user fees, and for other purposes.
What it does: Rewrites page 104, line 23 through page 105, line 14
Sen. Michael B. Enzi (R-WY)Rewrites page 104, line 23 through page 105, line 14
ReplacesPrinted pageRemoves page 104, line 23 through page 105, line 14 of the printed bill. See that page
Inserted: (II) the amount equal to one-fifth of the excess amount in item (bb), provided that--
Inserted: (aa) the amount of the total appropriation for the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of the total appropriation for the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1); and
Inserted: (bb) the amount of the total appropriations for the process of human drug review at the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of appropriations for the process of human drug review at the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1).
Inserted: In making the adjustment under subclause (II) for any fiscal year 2008 through 2012, subsection (c)(1) shall be applied by substituting '2007' for '2008.'
Original wording
Beginning on page 104, strike line 23 and all that follows through line 14 on page 105 and insert the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 1049. Mr. ENZI (for himself and Mr. Kennedy) submitted an amendment intended to be proposed by him to the bill S. 1082, to amend the Federal Food, Drug, and Cosmetic Act to reauthorize and amend the prescription drug user fee provisions, and for other purposes; which was ordered to lie on the table; as follows:
Beginning on page 104, strike line 23 and all that follows through line 14 on page 105 and insert the following:
“(II) the amount equal to one-fifth of the excess amount in item (bb), provided that--
“(aa) the amount of the total appropriation for the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of the total appropriation for the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1); and
“(bb) the amount of the total appropriations for the process of human drug review at the Food and Drug Administration for such fiscal year (excluding the amount of fees appropriated for such fiscal year) exceeds the amount of appropriations for the process of human drug review at the Food and Drug Administration for fiscal year 2007 (excluding the amount of fees appropriated for such fiscal year), adjusted as provided under subsection (c)(1).
In making the adjustment under subclause (II) for any fiscal year 2008 through 2012, subsection (c)(1) shall be applied by substituting ‘2007' for ‘2008.' ”.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment agreed to: Amendment SA 1049 as modified agreed to in Senate by Unanimous Consent.(text as modified: CR S5703-5704)
May 8, 2007
View full timeline
Senate amendment agreed to: Amendment SA 1049 as modified agreed to in Senate by Unanimous Consent.(text as modified: CR S5703-5704)
May 8, 2007
Senate amendment proposed (on the floor): Amendment SA 1049 proposed by Senator Brown for Senator Enzi.(consideration: CR S5699-5705)
May 8, 2007
Amendment SA 1049 proposed by Senator Brown for Senator Enzi. (consideration: CR S5699-5705) To modify provisions relating to user fees, and for other purposes.
May 8, 2007
Amendment SA 1049 as modified agreed to in Senate by Unanimous Consent. (text as modified: CR S5703-5704)
May 8, 2007
Senate amendment submitted
May 7, 2007